InnoCan Pharma
Developing over-the-counter Cannabinoid-based drugs for psoriasis and muscle and joint pains. Learn more
Launch date
Employees
Market cap
$50.3m
Enterprise valuation
$45m (Public information from Sep 2024)
Share price
CAD0.24 INNO.CN
Tel Aviv-Yafo Tel Aviv District (HQ)
Authorizing premium user...